An iterative algorithm for metabolic network-based drug target identification

Pacific Symposium on Biocomputing 2007, PSB 2007

Volumn , Issue , 2007, Pages 88-99

  Sridhar, Padmavati ^a   Kahveci, Tamer ^a   Ranka, Sanjay ^a  

^a University of Florida   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG TARGET IDENTIFICATION; DRUG TARGETS; EXHAUSTIVE SEARCH; FINITE NUMBER; ITERATIVE ALGORITHM; METABOLIC NETWORK; NETWORK-BASED; OPTIMAL SOLUTIONS; SIDE EFFECT; SUBOPTIMAL SOLUTION; TARGET COMPOUND;

ALGORITHMS; BIOINFORMATICS; ENZYME INHIBITION; ESCHERICHIA COLI; OPTIMAL SYSTEMS;

ITERATIVE METHODS;

ENZYME INHIBITOR;

ALGORITHM; ARTICLE; BIOLOGY; CHEMISTRY; DRUG DESIGN; DRUG EFFECT; ESCHERICHIA COLI; METABOLISM;

ALGORITHMS; COMPUTATIONAL BIOLOGY; DRUG DESIGN; ENZYME INHIBITORS; ESCHERICHIA COLI; METABOLISM;

EID: 38449123881     PISSN: None     EISSN: None     Source Type: Conference Proceeding    
DOI: None     Document Type: Conference Paper

References (24)

1. 'Proteome Mining' can zero in on Drug Targets. Duke University medical news, Aug 2004.
2. M Arita. The metabolic world of Escherichia coli is not small. PNAS, 101 (6): 1543-7, 2004.
3. S. Broder and J. C. Venter. Sequencing the Entire Genomes of Free-Living Organisms: The Foundation of Pharmacology in the New Millennium. Annual Review of Pharmacology and Toxicology, 40:97-132, Apr 2000.
4. S. K. Chanda and J. S. Caldwell. Fulfilling the promise: Drug discovery in the postgenomic era. Drug Discovery Today, 8(4):168-174, Feb 2003.
5. A. Comish-Bowden. Why is uncompetitive inhibition so rare? FEBS Letters, 203(1):3-6, Jul 1986.
6. A. Cornish-Bowden and J. S. Hofmeyr. The Role of Stoichiometric Analysis in Studies of Metabolism: An Example. Journal of Theoretical Biology, 216:179-191, May 2002.
7. J Drews. Drug Discovery: A Historical Perspective. Science, 287(5460):1960-1964, Mar 2000.
8. Davidov et. al. Advancing drug discovery through systems biology. Drug Discovery Today, 8(4):175-183, Feb 2003.
9. Deane et. al. Catechol-o-mefhyltransferase inhibitors versus active comparators for levodopa-induced complications in parkinson's disease. Cochrane Database of Systematic Reviews, 4, 2004.
10. Hatzimanikatis et. al. Metabolic networks: enzyme function and metabolite structure. Current Opinion in Structural Biology, (14):300-306, 2004.
11. Imielinski et. al. Investigating metabolite essentiality through genome scale analysis of E. coli production capabilities. Bioinformatics, Jan 2005.
12. Imoto et. al. Computational Strategy for Discovering Draggable Gene Networks from Genome-Wide RNA Expression Profiles. In PSB 2006 Online Proceedings, 2006.
13. Jeong et. al. Prediction of Protein Essentiality Based on Genomic Data. ComPlexUs, 1:19-28,2003.
14. Lemke et. al. Essentiality and damage in metabolic networks. Bioinformatics, 20(1):115-119, Jan 2004.
15. Ma et. al. Decomposition of metabolic network into functional modules based on the global connectivity structure of reaction graph. Bioinformatics, 20(12): 1870-6, 2004.
16. Mombach et. al. Bioinformatics analysis of mycoplasma metabolism: Important enzymes, metabolic similarities, and redundancy. Computers in Biology and Medicine 2005
17. Teichmann et. al. The Evolution and Structural Anatomy of the Small Molecule Metabolic Pathways in Escherichia coli. JMB, 311:693-708, 2001.
18. Yeh et. al. Computational Analysis of Plasmodium falciparum Metabolism: Organizing Genomic Information to Facilitate Drug Discovery. Genome Research, 14:917-924, 2004.
19. M Kanehisa and S Goto. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res., 28(l):27-30, Jan 2000.
20. C Smith. Hitting the target. Nature, 422:341-347, Mar 2003.
21. R. Somogyi and C.A. Sniegoski. Modeling the complexity of genetic networks: Understanding multi-gene and pleiotropic regulation. Complexity, 1:45-63, 1996.
22. P. Sridhar, T. Kahveci, and S. Ranka. Opmet: A metabolic network-based algorithm for optimal drug target identification. Technical report, CISE Department, University of Florida, Sep 2006.
23. R. Surtees and N. Blau. The neurochemistry of phenylketonuria. European Journal of Pediatrics, 159:109-13,2000.
24. Takenaka T. Classical vs reverse pharmacology in drag discovery. BJU International, 88(2):7-10, Sep 2001.